Disease/Infection News

RSS

Study could provide a new therapeutic target to reduce COVID-19 mortality

An enzyme with an elusive role in severe inflammation may be a key mechanism driving COVID-19 severity and could provide a new therapeutic target to reduce COVID-19 mortality, according to a study published in the Journal of Clinical Investigation.

25 Aug 2021

Reassuring news about the protection that SARS-CoV-2 vaccines offer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have proven effective at preventing COVID-19-related mortality and illness. Since no vaccine is 100% effective, breakthrough infections are likely to occur. New research by a group of scientists at Erasmus Medical Center and Radboud University in the Netherlands looked at vaccine-breakthrough infections in a large group of vaccinated healthcare workers (HCWs).

25 Aug 2021

CDC posts investigation notice regarding two multistate outbreaks of Salmonella infections

A CDC investigation notice regarding two multistate outbreaks of Salmonella infections has been posted: https://www.cdc.gov/salmonella/italian-style-meat-08-21/index.html

25 Aug 2021

Study: Majority of hospital-acquired COVID-19 cases were contracted from other patients

The majority of patients who contracted COVID-19 while in the hospital did so from other patients rather than from healthcare workers, concludes a new study from researchers at the University of Cambridge and Addenbrooke's Hospital.

25 Aug 2021

SARS-CoV-2 Delta likely to acquire resistance to wild-type spike vaccines

A new study published on the preprint server bioRxiv* explores the mechanism of the Delta variant's high infectivity and suggests a plausible pathway by which the Delta variant could escape from vaccine-induced immunity.

24 Aug 2021

Compounds from medicinal mushrooms may be our future weapon against SARS-CoV-2

Certain steroid-like compounds from Taiwan's endemic medicinal mushrooms (known as antcins) may inhibit a host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, thus, prevent viral infection and subsequent development of the coronavirus disease (COVID-19), reports a new study published in the MDPI's journal Plants.

24 Aug 2021

Researchers find clues to how lung damage develops in the aftermath of a respiratory infection

The deadliest time in a viral respiratory illness sometimes is actually after the virus is cleared from the body. Destructive processes that are set in motion during an infection crest in the weeks after the virus is defeated, leading to organ damage that can cause chronic illness or even death.

24 Aug 2021

UC San Diego Health performed region’s first double lung transplant for a COVID-19 patient

On a July afternoon, Federico Gomez Gil, 56, is dressed in a short-sleeved, collared shirt, sweatpants and a baseball cap. He sits in a chair in a hospital room, surrounded by his wife and two daughters. Given the past five months, this is the moment of a lifetime — a new lifetime.

24 Aug 2021

Do aerosol boxes prevent airborne spread of SARS-CoV-2?

An interesting new study describes a novel aerosol box design that has been produced and tested to prevent airborne transmission of SARS-CoV-2.

24 Aug 2021

Glycyrrhizic acid as a drug candidate for COVID-19

A new study presents the benefits of licorice, an age-old herbal remedy, to treat COVID-19 at all stages.

24 Aug 2021

COVID-19 with pre-eclampsia and acute fatty liver of pregnancy

A new study reports a case of pre-eclampsia complicated by the acute fatty liver of pregnancy (AFLP).

24 Aug 2021

New $14.5 million NIH grant to support research on HIV treatment and care in Central Africa

Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy have been awarded a five-year, $14.5 million grant from the National Institutes of Health to continue leading and expand their research on HIV treatment and care in five Central African nations.

24 Aug 2021

Disease/Infection News

Study could provide a new therapeutic target to reduce COVID-19 mortality

Reassuring news about the protection that SARS-CoV-2 vaccines offer

CDC posts investigation notice regarding two multistate outbreaks of Salmonella infections

Study: Majority of hospital-acquired COVID-19 cases were contracted from other patients

SARS-CoV-2 Delta likely to acquire resistance to wild-type spike vaccines

Compounds from medicinal mushrooms may be our future weapon against SARS-CoV-2

Researchers find clues to how lung damage develops in the aftermath of a respiratory infection

UC San Diego Health performed region’s first double lung transplant for a COVID-19 patient

Do aerosol boxes prevent airborne spread of SARS-CoV-2?

Glycyrrhizic acid as a drug candidate for COVID-19

COVID-19 with pre-eclampsia and acute fatty liver of pregnancy

New $14.5 million NIH grant to support research on HIV treatment and care in Central Africa

New clinical trial to test third dose of COVID-19 vaccine for immunocompromised people

Study identifies a key molecular mechanism driving COVID-19 mortality

Study shows difference in antibody levels in response to SARS-CoV-2 infection and type of vaccination

Researchers conduct population level observational study of the SARS-CoV-2 Alpha variant

Higher vaccination coverage is associated with lower COVID-19 incidence and hospitalization

The impact of COVID-19 on mental health and family finances

Antiviral strategy using synthetic peptoid has promising implications for fighting infection

Newly developed CPAP System provides a cost-effective respiratory device for COVID patients

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News